{{Rsnum
|rsid=3792109
|Gene=ATG16L1
|Chromosome=2
|position=233275771
|Orientation=minus
|GMAF=0.3774
|Gene_s=ATG16L1,SCARNA5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 55.8 | 30.1
| HCB | 41.6 | 44.5 | 13.9
| JPT | 59.3 | 37.2 | 3.5
| YRI | 61.2 | 35.4 | 3.4
| ASW | 57.9 | 38.6 | 3.5
| CHB | 41.6 | 44.5 | 13.9
| CHD | 58.3 | 36.1 | 5.6
| GIH | 27.7 | 48.5 | 23.8
| LWK | 71.8 | 26.4 | 1.8
| MEX | 51.7 | 36.2 | 12.1
| MKK | 55.1 | 41.7 | 3.2
| TSI | 14.7 | 58.8 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21102463
|Trait=None
|Title=Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|RiskAllele=A
|Pval=7E-41
|OR=1.3400
|ORtxt=[1.29-1.40]
|OA=1
}}

{{PMID Auto GWAS
  |PMID=22936669
  |Trait=Crohn's disease
  |Title=A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
  |RiskAllele=A
  |Pval=5E-9
  |OR=1.38
  |ORtxt=[NR]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}